Loading...

bioMérieux S.A.

BMXMF•PNK
HealthcareMedical - Diagnostics & Research
$136.00
$1.75(1.30%)

bioMérieux S.A. (BMXMF) Stock Overview

Explore bioMérieux S.A.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for BMXMFStats details for BMXMF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

CEO

Mr. Pierre Boulud

Employees

14,147

Headquarters

376 Chemin De l’Orme, Marcy l'Étoile

Founded

2017

Frequently Asked Questions